BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 1827135)

  • 1. Immunohistologic and ultrastructural comparison of the dermal papilla and hair follicle bulb from "active" and "normal" areas of alopecia areata.
    Hull SM; Nutbrown M; Pepall L; Thornton MJ; Randall VA; Cunliffe WJ
    J Invest Dermatol; 1991 May; 96(5):673-81. PubMed ID: 1827135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural abnormalities in the dermal papillae of both lesional and clinically normal follicles from alopecia areata scalps.
    Nutbrown M; MacDonald Hull SP; Baker TG; Cunliffe WJ; Randall VA
    Br J Dermatol; 1996 Aug; 135(2):204-10. PubMed ID: 8881661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ultrastructure of the dermal papilla-epithelial junction in normal and alopecia areata hair follicles.
    Nutbrown M; Hull SM; Thornton MJ; Cunliffe WJ; Randall VA
    Ann N Y Acad Sci; 1991 Dec; 642():476-7. PubMed ID: 1809111
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunofluorescent studies of complement C3 in the hair follicles of normal scalp and of scalp affected by alopecia areata.
    Igarashi R; Takeuchi S; Sato Y
    Acta Derm Venereol; 1980; 60(1):33-7. PubMed ID: 6153831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell degeneration in alopecia areata. An ultrastructural study.
    Tobin DJ; Fenton DA; Kendall MD
    Am J Dermatopathol; 1991 Jun; 13(3):248-56. PubMed ID: 1867355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alopecia areata: light and electron microscopic pathology of the regrowing white hair.
    Messenger AG; Bleehen SS
    Br J Dermatol; 1984 Feb; 110(2):155-62. PubMed ID: 6696834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal expression of Ki-67 antigen in hair follicle of alopecia areata.
    van Baar HM; Perret CM; van Vlijmen IM; van de Kerkhof PC; Happle R; Schalkwijk J
    Acta Derm Venereol; 1992; 72(3):161-4. PubMed ID: 1357847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hair follicle stem cell marker nestin expression in regenerating hair follicles of patients with alopecia areata.
    Amoh Y; Maejima H; Niiyama S; Mii S; Hamada Y; Saito N; Katsuoka K
    Eur J Dermatol; 2011; 21(2):209-12. PubMed ID: 21524985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of HLA-DR by anagen hair follicles in alopecia areata.
    Messenger AG; Bleehen SS
    J Invest Dermatol; 1985 Dec; 85(6):569-72. PubMed ID: 2415641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice.
    Gilhar A; Shalaginov R; Assy B; Serafimovich S; Kalish RS
    J Investig Dermatol Symp Proc; 1999 Dec; 4(3):207-10. PubMed ID: 10674367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis.
    Gupta AK; Ellis CN; Cooper KD; Nickoloff BJ; Ho VC; Chan LS; Hamilton TA; Tellner DC; Griffiths CE; Voorhees JJ
    J Am Acad Dermatol; 1990 Feb; 22(2 Pt 1):242-50. PubMed ID: 2138175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative image analysis of hair follicles in alopecia areata.
    Kim IH; Jo HY; Cho CG; Choi HC; Oh CH
    Acta Derm Venereol; 1999 May; 79(3):214-6. PubMed ID: 10384920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory autocrine factors produced by the mesenchyme-derived hair follicle dermal papilla may be a key to male pattern baldness.
    Hamada K; Randall VA
    Br J Dermatol; 2006 Apr; 154(4):609-18. PubMed ID: 16536801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alopecia areata: infiltration of Th17 cells in the dermis, particularly around hair follicles.
    Tanemura A; Oiso N; Nakano M; Itoi S; Kawada A; Katayama I
    Dermatology; 2013; 226(4):333-6. PubMed ID: 23838575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic cytotoxicity in alopecia areata: apoptosis of dermal papilla cells in alopecia areata.
    Norris DA; Duke R; Whang K; Middleton M
    J Invest Dermatol; 1995 May; 104(5 Suppl):8S-9S. PubMed ID: 7738399
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
    Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
    Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular activity in the dermis surrounding the hair bulb in alopecia areata.
    Pierard GE; De la Brassinne M
    J Cutan Pathol; 1975; 2(5):240-5. PubMed ID: 1214022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical and electron microscopic characterization of the cellular infiltrate in alopecia (areata, totalis, and universalis).
    Ranki A; Kianto U; Kanerva L; Tolvanen E; Johansson E
    J Invest Dermatol; 1984 Jul; 83(1):7-11. PubMed ID: 6376642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the dermal papilla a primary target in alopecia areata?
    Randall VA; Hull SP; Nutbrown M; Calver NS; Parkin SM; Cunliffe WJ
    J Invest Dermatol; 1995 May; 104(5 Suppl):7S-8S. PubMed ID: 7738398
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibodies to hair follicles in alopecia areata.
    Tobin DJ; Orentreich N; Fenton DA; Bystryn JC
    J Invest Dermatol; 1994 May; 102(5):721-4. PubMed ID: 8176253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.